ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Xingyun Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7699-4425; OpenAlex author ID A5090904507. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cancer: an interim evaluation of an ongoing p… Co-author DOI 10.20892/j.issn.2095-3941.2024.0287 ↗
Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. Co-author DOI 10.20892/j.issn.2095-3941.2024.0036 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuxiao Liu · 2 shared papers, 2024–2025 · strength 0.49
- Paper Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cance… DOI 10.20892/j.issn.2095-3941.2024.0287 ↗
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036 ↗
Jihui Hao · 2 shared papers, 2024–2025 · strength 0.49
- Paper Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cance… DOI 10.20892/j.issn.2095-3941.2024.0287 ↗
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036 ↗
Chuntao Gao · 1 shared paper, 2025 · strength 0.27
- Paper Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cance… DOI 10.20892/j.issn.2095-3941.2024.0287 ↗
Wei Wang · 1 shared paper, 2025 · strength 0.27
- Paper Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cance… DOI 10.20892/j.issn.2095-3941.2024.0287 ↗
Haorui Li · 1 shared paper, 2025 · strength 0.27
- Paper Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cance… DOI 10.20892/j.issn.2095-3941.2024.0287 ↗
Rui Liu · 1 shared paper, 2025 · strength 0.27
- Paper Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cance… DOI 10.20892/j.issn.2095-3941.2024.0287 ↗
Wenbo Zhu · 1 shared paper, 2024 · strength 0.22
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036 ↗
Jing Huang · 1 shared paper, 2024 · strength 0.22
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036 ↗
Xiaofan Guo · 1 shared paper, 2024 · strength 0.22
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036 ↗
Song Gao · 1 shared paper, 2024 · strength 0.22
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.